Interview fractional leaders this week for free!

Biogen

Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases.

Est. revenue: $1B–$1000B
Employees: 7,834

Claim profile

Funding & revenue at Biogen

How well capitalized the business is — useful context before you scope a fractional engagement or negotiate a rate.

Estimated annual revenue

$1B–$1000B

Modeled range, not company-reported

Publicly traded

BIOGEN, BIIB

Growth signals

How fast Biogen is adding people, roles, and audience.

Employees

7,834

Reported band 5001-10000

Open roles

-1% year over year

LinkedIn followers

1.3M

+13.8% year over year

Headcount change

MoM: +0.1%; +6 people
QoQ: +0.2%; +17 people
6mo: +2.3%; +177 people
YoY: +0.2%; +18 people
2yr: -4.1%; -332 people

Team composition

Where Biogen concentrates its people — a read on which function a fractional leader would plug into.

By function

Research1,30317%
Operations90212%
Sales6989%
Healthcare Services5928%
Business Development5747%
Information Technology5036%
Engineering4756%
Quality Assurance3384%

By region

United States4,505
Greater Boston1,915
Massachusetts, United States1,854
North Carolina, United States1,401
Raleigh Durham Chapel Hill Area1,340
Switzerland737

Inside Biogen

What the business focuses on, where it operates, and how employees rate it.

Markets

PRIVATENASDAQ

Offices

Landis & Gyr-Strasse 3, Zug, CH 6300, CH
P.O. Box 14627, Research Triangle Park, NC, 27709, US

Biogen in the news

Recent coverage picked up alongside the firmographic refresh.

Jobs

Post a role →

Interim Senior Market Access Manager